Profound Medical Corp.

NASDAQ:PROF

Medical - Devices

Healthcare
$6.59 +4.11%

+$0.27 today

Market cap
$241.37M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $3.76High $8.95

Volume 0.10M

Average 0.12M

Returns on capital

Profound Medical Corp. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-47.6%

avg -71.7%

ROIC

-22.7%

avg -53.8%

ROA

-22.4%

avg -48.6%

Analysis

ROA is currently the strongest return metric at -22.4% versus its period average of -48.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Arun Swarup Menawat

Chairman of the Board & Chief Executive OfficerCAD 998.59K71587.09K1.94%

Mathieu Burtnyk

Chief Technology OfficerCAD 479.84K44——

Richard R. Fabian

PresidentCAD 479.84K59——

Thomas Tamberrino

Chief Commercial OfficerCAD 382.2K46——

Matthew Sobczyk

Interim Chief Financial Officer—42——

Stephen Kilmer

Investor Relations————

Levant Tinaz

Software Developer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding May 16, 2025.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+34.8%
+53.4% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +34.8% over three years. Forward estimates point to Revenue at +53.4% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Profound Medical Corp. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about PROF's management, answered from reported figures.

Who manages PROF?

Profound Medical Corp. (PROF) lists 7 active executives. The top listed executive is Arun Swarup Menawat, Chairman of the Board & Chief Executive Officer.

Are PROF insiders buying or selling?

Recent insider activity shows net buying of $100,150.69.